Protein phosphatase 2A Aα regulates Aβ protein expression and stability

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• Protein phosphatase 2A (PP2A) is a crucial tumor suppressor that inhibits oncogenic signaling pathways.
• PP2A's function relies on its three subunits, including the scaffolding A subunit with Aα and Aβ isoforms.
• Complete loss of the Aα isoform, unlike partial loss, does not promote tumorigenesis, a phenomenon observed in cancer patients.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the lack of tumor-promoting properties upon complete loss of the PP2A Aα isoform.
• To understand why Aα is inactivated in a haploinsufficient manner in cancer patients.

Main Methods:

• CRISPR/Cas9-mediated homozygous Aα deletion in cancer cell lines.
• Analysis of PP2A family member protein expression and stability.
• Cellular assays including colony formation and tumor growth.
• Biochemical assays such as co-immunoprecipitation.

Main Results:

• Homozygous Aα deletion led to decreased colony formation and tumor growth.
• Aα deletion significantly upregulated Aβ protein expression by enhancing its stability.
• Aβ was essential for cell survival in Aα-deficient cells.
• Aα deficiency resulted in increased binding of regulatory subunits to Aβ, which was reversed by regulatory subunit knockdown.

Conclusions:

• PP2A Aα regulates the stability and activity of the Aβ isoform.
• Upregulation of Aβ compensates for the loss of Aα, explaining why complete Aα loss is not transformative.
• This compensatory mechanism suggests why homozygous Aα loss is rare in cancer.